Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

687 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis.
Hutton J, Mease P, Jadon D. Hutton J, et al. Among authors: mease p. Best Pract Res Clin Rheumatol. 2022 Dec;36(4):101809. doi: 10.1016/j.berh.2022.101809. Epub 2022 Dec 23. Best Pract Res Clin Rheumatol. 2022. PMID: 36567224 Free article. Review.
Novel therapies in axial spondyloarthritis.
Bittar M, Mease P. Bittar M, et al. Among authors: mease p. Best Pract Res Clin Rheumatol. 2022 Dec;36(4):101811. doi: 10.1016/j.berh.2022.101811. Epub 2022 Dec 22. Best Pract Res Clin Rheumatol. 2022. PMID: 36566165 Review.
Fibromyalgia syndrome module at OMERACT 9: domain construct.
Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA; OMERACT Fibromyalgia Working Group. Mease P, et al. J Rheumatol. 2009 Oct;36(10):2318-29. doi: 10.3899/jrheum.090367. J Rheumatol. 2009. PMID: 19820221 Free PMC article.
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis.
Rahman P, Boehncke WH, Mease PJ, Gottlieb AB, McInnes IB, Shawi M, Wang Y, Sheng S, Kollmeier AP, Theander E, Yu J, Leibowitz E, Marrache AM, Coates LC. Rahman P, et al. Among authors: mease pj. J Rheumatol. 2023 Jun;50(6):769-780. doi: 10.3899/jrheum.220928. Epub 2023 Jan 15. J Rheumatol. 2023. PMID: 36642439 Free article. Clinical Trial.
Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system.
Wei Q, Mease PJ, Chiorean M, Iles-Shih L, Matos WF, Baumgartner A, Molani S, Hwang YM, Belhu B, Ralevski A, Hadlock J. Wei Q, et al. medRxiv [Preprint]. 2023 Jun 28:2023.06.26.23291904. doi: 10.1101/2023.06.26.23291904. medRxiv. 2023. PMID: 37425752 Free PMC article. Updated. Preprint.
687 results